Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.

Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized control...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Parry, C, Thieu, N, Dolecek, C, Karkey, A, Gupta, R, Turner, P, Dance, D, Maude, R, Ha, V, Tran, C, Thi, P, Be, b, Phi, L, Ngoc, R, Ghose, A, Dongol, S, Campbell, J, Thanh, D, Thanh, T, Moore, C, Sona, S, Gaind, R, Deb, M, Anh, H, Van, S, Tinh, H, Day, N, Dondorp, A, Thwaites, G, Faiz, M, Phetsouvanh, R, Newton, P, Basnyat, B, Farrar, J, Baker, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	American Society of Microbiology 2015

Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.

Benzer Materyaller